The efficacy of bendamustine and rituximab in the treatment of indolent lymphoma diseases

NKTR-102: a new drug for treating platinum-resistant or refractory ovarian cancer

Progress in myeloma survival rates

Conatumumab or AMG 479 as treatment for pancreatic cancer

Roundup of the 2010 ASCO conference

Breast cancers that spread to the liver may change biology, impacting treatment effectiveness

ALK inhibitor shows high response rate in patients with advanced NSCLC harboring a specific gene alteration

New agent, eribulin, derived from marine sponge, increases survival among women with metastatic breast cancer

Antibody drug ipilimumab improves long-term survival in previously treated advanced melanoma

The role of genetic mutations in lung cancer

The use of monoclonal antibodies to treat mesothelioma

Tumour circulating cells